{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:29:03Z","timestamp":1776900543783,"version":"3.51.2"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sichuan Province Regional innovation cooperation project","award":["2024YFHZ0215"],"award-info":[{"award-number":["2024YFHZ0215"]}]},{"name":"State Key Laboratory of Oral Diseases (SKLOD) Open Fun","award":["SKLOD2024OF02"],"award-info":[{"award-number":["SKLOD2024OF02"]}]},{"name":"Key Project of the Sichuan Provincial Health Commission's Clinical Research Program","award":["24LCYJZD06"],"award-info":[{"award-number":["24LCYJZD06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thyroid Res"],"DOI":"10.1186\/s13044-024-00222-7","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T23:02:16Z","timestamp":1740524536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Celastrol promotes apoptotic cell death in thyroid cancer cells through a caspases-dependent pathway"],"prefix":"10.1186","volume":"18","author":[{"given":"Ruoyi","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Shui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"issue":"3","key":"222_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"222_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.mam.2010.02.006","volume":"31","author":"MG Catalano","year":"2010","unstructured":"Catalano MG, Poli R, Pugliese M, et al. Emerging molecular therapies of advanced thyroid cancer. Mol Aspects Med. 2010;31(2):215\u201326.","journal-title":"Mol Aspects Med"},{"issue":"3","key":"222_CR3","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.3390\/ijms16036153","volume":"16","author":"P Fallahi","year":"2015","unstructured":"Fallahi P, Mazzi V, Vita R, et al. New therapies for dedifferentiated papillary thyroid cancer. Int J Mol Sci. 2015;16(3):6153\u201382.","journal-title":"Int J Mol Sci"},{"key":"222_CR4","doi-asserted-by":"crossref","unstructured":"Fagin JA, Wells SA, JR. Biologic and Clinical Perspectives on Thyroid Cancer. N Engl J Med. 2016;375(11):1054\u201367.","DOI":"10.1056\/NEJMra1501993"},{"issue":"3","key":"222_CR5","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3892\/or.2017.5364","volume":"37","author":"J Xu","year":"2017","unstructured":"Xu J, Li Z, Su Q, et al. TRIM29 promotes progression of thyroid carcinoma via activating P13K\/AKT signaling pathway. Oncol Rep. 2017;37(3):1555\u201364.","journal-title":"Oncol Rep"},{"issue":"1","key":"222_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12957-016-0772-1","volume":"14","author":"J Hu","year":"2016","unstructured":"Hu J, Zhao N, Kong R, et al. Total thyroidectomy as primary surgical management for thyroid disease: surgical therapy experience from 5559 thyroidectomies in a less-developed region. World J Surg Oncol. 2016;14(1):20.","journal-title":"World J Surg Oncol"},{"issue":"3","key":"222_CR7","first-page":"247","volume":"48","author":"TG Pemayun","year":"2016","unstructured":"Pemayun TG. current diagnosis and management of thyroid nodules. Acta Med Indones. 2016;48(3):247\u201357.","journal-title":"Acta Med Indones"},{"key":"222_CR8","doi-asserted-by":"crossref","unstructured":"Hu J, Yuan IJ, Mirshahidi S, et al. Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy. Int J Mol Sci. 2021;22(4):1950.","DOI":"10.3390\/ijms22041950"},{"issue":"2","key":"222_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ando.2021.12.002","volume":"83","author":"M Puerto","year":"2022","unstructured":"Puerto M, Borson-Chazot F, Tabarin A. Updates on therapy for medullary thyroid cancer in 2021. Ann Endocrinol (Paris). 2022;83(2):114\u20138.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"3","key":"222_CR10","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3803\/EnM.2021.1082","volume":"36","author":"M Kim","year":"2021","unstructured":"Kim M, Kim BH. Current Guidelines for Management of Medullary Thyroid Carcinoma. Endocrinol Metab (Seoul). 2021;36(3):514\u201324.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"6","key":"222_CR11","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1515\/jpem-2015-0309","volume":"29","author":"Z Nozhat","year":"2016","unstructured":"Nozhat Z, Hedayati M. Medullary thyroid carcinoma: a review on ethical considerations in treatment of children. J Pediatr Endocrinol Metab. 2016;29(6):633\u20139.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"7","key":"222_CR12","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1530\/ERC-21-0368","volume":"29","author":"A Angelousi","year":"2022","unstructured":"Angelousi A, Hayes AR, Chatzellis E, et al. Metastatic medullary thyroid carcinoma: a new way forward. Endocr Relat Cancer. 2022;29(7):R85-r103.","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"222_CR13","first-page":"5888","volume":"11","author":"B Lin","year":"2019","unstructured":"Lin B, Ma H, Ma M, et al. The incidence and survival analysis for anaplastic thyroid cancer: a SEER database analysis. Am J Transl Res. 2019;11(9):5888\u201396.","journal-title":"Am J Transl Res"},{"issue":"4","key":"222_CR14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1245\/ASO.2006.05.042","volume":"13","author":"C Are","year":"2006","unstructured":"Are C, Shaha AR. Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol. 2006;13(4):453\u201364.","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"222_CR15","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1089\/thy.2012.0302","volume":"22","author":"RC Smallridge","year":"2012","unstructured":"Smallridge RC, Ain KB, Asa SL, et al. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 2012;22(11):1104\u201339.","journal-title":"Thyroid"},{"issue":"3","key":"222_CR16","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3390\/cancers7030855","volume":"7","author":"M Hong","year":"2015","unstructured":"Hong M, Wang N, Tan HY, et al. MicroRNAs and Chinese medicinal herbs: new possibilities in cancer therapy. Cancers (Basel). 2015;7(3):1643\u201357.","journal-title":"Cancers (Basel)"},{"key":"222_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13020-019-0249-6","volume":"14","author":"Y Luo","year":"2019","unstructured":"Luo Y, Feng Y, Song L, et al. A network pharmacology-based study on the anti-hepatoma effect of Radix Salviae Miltiorrhizae. Chin Med. 2019;14:27.","journal-title":"Chin Med"},{"key":"222_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ejmech.2019.05.009","volume":"177","author":"Z Chen","year":"2019","unstructured":"Chen Z, Zhang D, Yan S, et al. SAR study of Celastrol analogs targeting Nur77-mediated inflammatory pathway. Eur J Med Chem. 2019;177:171\u201387.","journal-title":"Eur J Med Chem"},{"issue":"10","key":"222_CR19","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.18632\/aging.101302","volume":"9","author":"D Luo","year":"2017","unstructured":"Luo D, Guo Y, Cheng Y, et al. Natural product Celastrol suppressed macrophage M1 polarization against inflammation in diet-induced obese mice via regulating Nrf2\/HO-1 MAP kinase and NF-\u03baB pathways. Aging (Albany NY). 2017;9(10):2069\u201382.","journal-title":"Aging (Albany NY)"},{"key":"222_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phymed.2018.09.181","volume":"54","author":"FZ Lin","year":"2019","unstructured":"Lin FZ, Wang SC, Hsi YT, et al. Celastrol induces vincristine multidrug resistance oral cancer cell apoptosis by targeting JNK1\/2 signaling pathway. Phytomedicine. 2019;54:1\u20138.","journal-title":"Phytomedicine"},{"issue":"1","key":"222_CR21","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13046-019-1173-4","volume":"38","author":"X Liu","year":"2019","unstructured":"Liu X, Zhao P, Wang X, et al. Celastrol mediates autophagy and apoptosis via the ROS\/JNK and Akt\/mTOR signaling pathways in glioma cells. J Exp Clin Cancer Res. 2019;38(1):184.","journal-title":"J Exp Clin Cancer Res"},{"key":"222_CR22","doi-asserted-by":"publisher","first-page":"673209","DOI":"10.3389\/fphar.2021.673209","volume":"12","author":"PR Wagh","year":"2021","unstructured":"Wagh PR, Desai P, Prabhu S, et al. Nanotechnology-Based Celastrol Formulations and Their Therapeutic Applications. Front Pharmacol. 2021;12:673209.","journal-title":"Front Pharmacol"},{"issue":"Suppl 1","key":"222_CR23","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.ijsu.2017.02.064","volume":"41","author":"G Accardo","year":"2017","unstructured":"Accardo G, Conzo G, Esposito D, et al. Genetics of medullary thyroid cancer: An overview. Int J Surg. 2017;41(Suppl 1):S2-s6.","journal-title":"Int J Surg"},{"issue":"12","key":"222_CR24","doi-asserted-by":"publisher","first-page":"a009233","DOI":"10.1101\/cshperspect.a009233","volume":"5","author":"M Santoro","year":"2013","unstructured":"Santoro M, Carlomagno F. Central role of RET in thyroid cancer. Cold Spring Harb Perspect Biol. 2013;5(12):a009233.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"222_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.annonc.2020.10.599","volume":"32","author":"V Subbiah","year":"2021","unstructured":"Subbiah V, Shen T, Terzyan SS, et al. Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations. Ann Oncol. 2021;32(2):261\u20138.","journal-title":"Ann Oncol"},{"issue":"2","key":"222_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ecl.2021.11.020","volume":"51","author":"A Maniakas","year":"2022","unstructured":"Maniakas A, Zafereo M, Cabanillas ME. Anaplastic Thyroid Cancer: New Horizons and Challenges. Endocrinol Metab Clin North Am. 2022;51(2):391\u2013401.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"222_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41392-022-01231-4","volume":"8","author":"H Xu","year":"2023","unstructured":"Xu H, Zhao H, Ding C, et al. Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1 [J]. Signal Transduct Target Ther. 2023;8(1):51.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"222_CR28","first-page":"877","volume":"42","author":"Y Ye","year":"2022","unstructured":"Ye Y, Aihui Z, Anmao LI. Celastrol promotes apoptotic cell death in children neuroblastoma cells through caspases dependent pathway. J Tradit Chin Med. 2022;42(6):877\u201384.","journal-title":"J Tradit Chin Med"},{"issue":"1","key":"222_CR29","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12967-022-03741-9","volume":"20","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Wang Y, Gong Y, et al. Celastrol elicits antitumor effects by inhibiting the STAT3 pathway through ROS accumulation in non-small cell lung cancer. J Transl Med. 2022;20(1):525.","journal-title":"J Transl Med"}],"container-title":["Thyroid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-024-00222-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13044-024-00222-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-024-00222-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T23:02:25Z","timestamp":1740524545000},"score":1,"resource":{"primary":{"URL":"https:\/\/thyroidresearchjournal.biomedcentral.com\/articles\/10.1186\/s13044-024-00222-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["222"],"URL":"https:\/\/doi.org\/10.1186\/s13044-024-00222-7","relation":{},"ISSN":["1756-6614"],"issn-type":[{"value":"1756-6614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"12 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics Committee for Medical Research and New Medical Technology of Sichuan Cancer Hospital (SCCHEC-02\u20132024-109).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}